We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$11.5B
AUM Growth
+$6.31B
Cap. Flow
+$5.08B
Cap. Flow %
44.03%
Top 10 Hldgs %
42.58%
Holding
980
New
298
Increased
138
Reduced
168
Closed
338

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$281M
2
BKNG icon
Booking.com
BKNG
+$169M
3
HUM icon
Humana
HUM
+$76.2M
4
RGTI icon
Rigetti Computing
RGTI
+$74.6M
5
MSTR icon
Strategy Inc
MSTR
+$74.1M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$359M
2
BRRR icon
Coinshares Bitcoin ETF
BRRR
+$210M
3
NVDA icon
NVIDIA
NVDA
+$157M
4
AVGO icon
Broadcom
AVGO
+$123M
5
NFLX icon
Netflix
NFLX
+$114M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Financials 8.74%
3 Consumer Discretionary 7.67%
4 Healthcare 7.01%
5 Industrials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTNP
601
DELISTED
Titan Pharmaceuticals
TTNP
$44.8K ﹤0.01%
+10,663
New +$45.2K
WOLF icon
602
Wolfspeed
WOLF
$1.35B
$43.7K ﹤0.01%
108,829
+57,470
+112% +$131K
NAK
603
Northern Dynasty Minerals
NAK
$958M
$43.2K ﹤0.01%
32,267
-1,732,933
-98% -$1.93M
HXHX
604
Haoxin Holdings
HXHX
$7.04M
$42.9K ﹤0.01%
+27,871
New +$46.6K
TANH icon
605
Tantech Holdings
TANH
$6.23M
$42.6K ﹤0.01%
+21,737
New +$44.5K
USGOW
606
DELISTED
U.S. GoldMining Inc Warrant
USGOW
$41.2K ﹤0.01%
45,229
+7,500
+20% +$8.43K
TLRY icon
607
Tilray
TLRY
$493M
$39.6K ﹤0.01%
9,565
-46,214
-83% -$210K
ABOS icon
608
Acumen Pharmaceuticals
ABOS
$157M
$38.6K ﹤0.01%
33,300
MTC icon
609
MMTec
MTC
$294M
$35.8K ﹤0.01%
+34,212
New +$35.2K
OSS icon
610
One Stop Systems
OSS
$330M
$35.5K ﹤0.01%
+10,000
New +$27.9K
UOKA
611
DELISTED
MDJM Ltd
UOKA
$31.4K ﹤0.01%
+352
New +$37.6K
TSHA icon
612
Taysha Gene Therapies
TSHA
$1.68B
$28.9K ﹤0.01%
12,500
AUTL
613
Autolus Therapeutics
AUTL
$405M
$28.5K ﹤0.01%
12,500
MREO
614
Mereo BioPharma
MREO
$46.4M
$27.1K ﹤0.01%
10,000
MRDN
615
Meridian Holdings Inc
MRDN
$153M
$26.1K ﹤0.01%
1,277
BMGL
616
Basel Medical
BMGL
$8.8M
$24.8K ﹤0.01%
+1,160
New +$51K
DXST
617
Decent Holding Inc
DXST
$4.96M
$22.8K ﹤0.01%
+666
New +$19.7K
MGX icon
618
Metagenomi Therapeutics
MGX
$45.9M
$22.2K ﹤0.01%
15,000
WAFU icon
619
Wah Fu Education Group
WAFU
$7.06M
$20.6K ﹤0.01%
+14,694
New +$21.2K
GIBO
620
GIBO Holdings
GIBO
$79.2M
$20.5K ﹤0.01%
+28
New +$337K
ACRS icon
621
Aclaris Therapeutics
ACRS
$765M
$20.4K ﹤0.01%
14,400
EPWK
622
DELISTED
EPWK Holdings
EPWK
$20.4K ﹤0.01%
+972
New +$247K
CGC
623
Canopy Growth
CGC
$382M
$20K ﹤0.01%
16,373
-44,760
-73% -$59.5K
NCEW
624
New Century Logistics (BVI) Ltd
NCEW
$53.8M
$19.6K ﹤0.01%
2,589
+1,064
+70% +$12.5K
BLNK icon
625
Blink Charging
BLNK
$79.6M
$18.8K ﹤0.01%
20,000
-1,408
-7% -$1.12K

Similar funds

Marex Group's Q2 2025 Portfolio in Review

As of Q2 2025, Marex Group held 980 positions worth $11.5B, up 121% from $5.22B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Marex Group deployed $5.08B of net new capital in Q2 2025, opening 298 new positions and adding to 138 existing holdings. Its largest new stake was Humana: 305,720 shares worth $74.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $359M trimmed.

  • Marex Group's largest Q2 2025 buy was Humana: 305,720 shares worth $74.7M.
  • Marex Group added most to Mastercard in Q2 2025, an estimated $281M increase.
  • Marex Group's biggest Q2 2025 reduction was iShares Bitcoin Trust, cutting an estimated $359M.
  • Marex Group fully exited Coinshares Bitcoin ETF in Q2 2025, selling an estimated $210M.
  • Marex Group's ten largest holdings make up 43% of its $11.5B portfolio in Q2 2025.
  • Marex Group opened 298 new positions and closed 338 in Q2 2025.
  • Marex Group's portfolio value rose 121% quarter-over-quarter to $11.5B.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.